The Neurodivergent Apothecary- Rooted in Different
- Feb 18
- 30 min read
Updated: 6d
What grows in the gap between masking and medicating.
SUPPLEMENTS FOR NEURODIVERGENT BRAINS
A Targeted Guide: Mushrooms, Adaptogens & Roots Mapped to Core ND Friction Domains
Emotional Regulation · RSD · Sensory Processing · Executive Function · Motor · Rhythms & Sleep · Anxiety · Nervous System · Memory · Burnout · Identity...

Why This Guide Exists
You've tried the medication. Or decided against it. You've learned to mask — and learned what masking costs. You know your nervous system. You've read the research, done the therapy, built the systems.
And still. The cortisol that won't clear. The sensory day that takes three days to recover from. The emotional response that arrives before you've finished the thought.
There's a layer most conversations about neurodivergence never reach. Not psychological. Not behavioral. Biological — the HPA axis running too hot, the dopamine that misfires, the prefrontal circuits that go offline under load. (Barkley, 2015; Porges, 2011)
That layer responds to things that grow. Medicinal mushrooms that stimulate nerve growth factor. Adaptogens that recalibrate cortisol. Roots that cross the blood-brain barrier and reduce the neuroinflammation that turns ordinary input into overwhelm. (Lai et al., 2013; Chandrasekhar et al., 2012)
This guide is about that layer. Friction domain by friction domain. What the evidence says. What the mechanism is. What grows in the gap between masking and medicating.
None of this replaces anything. It sits alongside. It fills a gap that most clinical conversations about neurodivergence don't even know is there.
It maps what's in that gap.
Friction by friction. Mechanism by mechanism. With the evidence attached.
⚠️ Important This guide is for educational purposes only. Supplements interact with medications — including ADHD medication (especially stimulants, which interact with several adaptogens), SSRIs, and thyroid medication. Always consult your prescriber before adding supplements. Nothing here replaces professional medical or psychiatric care. |
While many mushroom compounds dissolve happily in water, some of their more intriguing constituents appreciate a little healthy fat — not essential, just better with good company.
Master Overview: Friction Domains × Supplements
Every friction domain. Every supplement that speaks to it. The mechanism. The evidence. One table.
Start here.
ND Friction Domain | Primary Supplements | Key Mechanism | Evidence Level |
Emotional Regulation | Ashwagandha, Reishi, Lion's Mane, Bacopa, Rhodiola | HPA axis regulation; cortisol reduction; amygdala modulation; NGF/BDNF | Strong (Ashwagandha, Rhodiola); Moderate (Lion's Mane, Bacopa) |
Rejection Sensitive Dysphoria | Ashwagandha, Rhodiola, Mucuna Pruriens, Bacopa | Noradrenergic calming; cortisol reduction; dopamine precursor support | Moderate; no RSD-specific RCTs yet — mechanism-based rationale |
Sensory Processing | Reishi, Ashwagandha, Lion's Mane, Magnesium, Holy Basil | Nervous system downregulation; GABA-A modulation; neuroinflammation reduction | Moderate (nervous system); Emerging (sensory-specific) |
Executive Function | Lion's Mane, Bacopa, Panax Ginseng, Rhodiola, Cordyceps | NGF/BDNF; acetylcholinesterase inhibition; dopamine/NE support; cerebral blood flow | Strong (Bacopa, Ginseng, Rhodiola); Moderate (Lion's Mane) |
Motor & Coordination | Lion's Mane, Cordyceps, Curcumin, Magnesium, CoQ10 | Nerve growth; ATP production; anti-inflammatory; mitochondrial support | Emerging (nerve regeneration); Strong (energy, anti-inflammatory) |
Rhythms & Time / Sleep | Ashwagandha, Reishi, Valerian, Magnesium Glycinate, Lion's Mane | Circadian rhythm regulation; cortisol normalization; GABA modulation; sleep architecture | Strong (Ashwagandha, Magnesium, Valerian); Moderate (Reishi) |
Social & Communication / Masking Fatigue | Reishi, Ashwagandha, Rhodiola, Eleuthero, Holy Basil | Stress resilience; adrenal recovery; cortisol regulation post-masking | Strong (adaptogens for stress); Extrapolated for masking fatigue |
Cognitive Style & Processing | Lion's Mane, Bacopa, Ginkgo Biloba, Panax Ginseng, Rhodiola | NGF; memory consolidation; cerebral circulation; processing speed support | Strong (Bacopa, Ginkgo, Ginseng); Moderate-Strong (Lion's Mane) |
Nervous System Regulation | Ashwagandha, Reishi, Holy Basil, Valerian, Magnesium, Schisandra | HPA axis; GABA-A; vagal tone support; neuroinflammation; cortisol clearance | Strong (Ashwagandha, Magnesium); Moderate (Reishi, Holy Basil) |
Anxiety & Threat Detection | Ashwagandha, Bacopa, Rhodiola, Valerian, Holy Basil, Passionflower | Cortisol reduction; GABA-A modulation; amygdala downregulation; anxiolytic | Strong (Ashwagandha, Valerian, Bacopa); Moderate (Rhodiola) |
RSD & Emotional Pain | Ashwagandha, Rhodiola, Mucuna Pruriens, Saffron | Norepinephrine regulation; cortisol; dopamine precursor; serotonin modulation | Mechanism-based; clinical extrapolation from anxiety/mood RCTs |
Memory & Learning | Bacopa, Lion's Mane, Ginkgo Biloba, Panax Ginseng, Rhodiola | Acetylcholinesterase inhibition; NGF; cerebral blood flow; synaptic density | Strong (Bacopa, Ginkgo); Moderate-Strong (Lion's Mane, Ginseng) |
Interoception & Body Signals | Ashwagandha, Magnesium, Lion's Mane, Reishi | Cortisol normalization; nervous system tone; neural signaling support | Emerging; mechanism-based rationale |
Identity, Shame & Burnout | Ashwagandha, Rhodiola, Reishi, Eleuthero, Schisandra, Lion's Mane | Adrenal recovery; HPA axis reset; neuroprotection; cognitive restoration post-burnout | Strong (burnout/exhaustion); Extrapolated to ND-specific burnout |
Sleep Architecture | Ashwagandha, Reishi, Magnesium Glycinate, Valerian, L-Theanine, Lion's Mane | GABA modulation; cortisol evening reduction; sleep onset; REM quality | Strong (Ashwagandha, Magnesium, Valerian); Moderate (Reishi, L-Theanine) |
Supplement Profiles: What Each One Addresses
This table profiles each supplement from the perspective of ND friction — which domains it addresses, what its key mechanism is, and how strong the evidence base is.
Supplement | Type | ND Friction Domains Addressed | Key Compound / Mechanism | Evidence |
Lion's Mane | Mushroom | Executive function, Memory, Cognitive processing, Nervous system repair, Emotional regulation, Motor support | Erinacines → NGF & BDNF synthesis; myelination support | Moderate-Strong |
Reishi | Mushroom | Nervous system regulation, Anxiety, Sleep, Social/Masking fatigue, Sensory overwhelm, Immune-neural axis | Triterpenoids → cortisol; Beta-glucans → immune/neural modulation | Moderate-Strong |
Cordyceps | Mushroom | Motor energy, Executive fatigue, Physical endurance, Burnout recovery, Cognitive stamina | Cordycepin → ATP; VO2 max; mitochondrial efficiency | Moderate (human) |
Turkey Tail | Mushroom | Gut-brain axis, Immune-neural regulation, Post-illness ND symptom worsening | PSK/PSP → gut microbiome; NK cell activation | Strong (immune); Emerging (gut-brain-ND) |
Chaga | Mushroom | Neuroinflammation, Oxidative stress in the brain, Immune-neural dysregulation | Betulinic acid; melanin → anti-inflammatory, antioxidant | Preclinical-Moderate |
Ashwagandha | Adaptogen | Emotional regulation, RSD, Anxiety, Nervous system, Sleep, Burnout, Masking fatigue, Executive function | Withanolides → HPA axis; GABA-A modulation; cortisol reduction | Strong |
Rhodiola Rosea | Adaptogen | Executive function, Cognitive stamina, Emotional regulation, RSD, Burnout, Anxiety, Time/rhythm fatigue | Rosavins/Salidroside → MAO inhibition; AMPK; cortisol | Strong |
Bacopa Monnieri | Adaptogen/Herb | Memory, Learning, Executive function, Anxiety, Cognitive processing, Working memory | Bacosides → AChE inhibition; BDNF; synaptic density | Strong |
Ashwagandha (KSM-66) | Adaptogen | Sleep onset, Cortisol at night, Delayed sleep phase, Anxiety-driven insomnia | Withanolides → evening cortisol; GABA-A; sleep architecture normalization | Strong |
Panax Ginseng | Adaptogen/Root | Executive function, Working memory, Cognitive processing, Fatigue, Blood sugar regulation | Ginsenosides → dopamine/NE; cerebral circulation; glucose metabolism | Strong |
Eleuthero | Adaptogen/Root | Burnout recovery, Masking fatigue, Adrenal recovery, Physical endurance | Eleutherosides → adrenal gland; NK cells; mild stimulant | Moderate |
Astragalus | Root | Immune-neural axis, Cellular aging in ND, Long-term neuroprotection | Astragalosides → telomerase; T-cell; anti-inflammatory | Moderate-Strong (immune) |
Schisandra | Berry/Adaptogen | Burnout, Liver-brain axis, Cognitive clarity post-overwhelm, Adrenal fatigue | Schisandrins → CYP450 liver; mitochondrial; CNS adaptogen | Moderate |
Holy Basil (Tulsi) | Adaptogen | Anxiety, Nervous system regulation, Blood sugar stability, Cortisol, Masking fatigue | Eugenol; ursolic acid → cortisol; COX-2; neuroprotective | Moderate |
Valerian Root | Root | Sleep onset, Anxiety, Nervous system downregulation, Sensory overwhelm at bedtime | Valerenic acid → GABA-A modulation; sedation without dependency | Moderate-Strong |
Maca Root | Root | Hormonal regulation in ND, Energy, Libido, Mood stability, Dopamine modulation | Macamides; glucosinolates → dopamine; estrogen/progesterone balance | Moderate |
Ginkgo Biloba | Tree Extract | Cerebral blood flow, Memory, Executive function, Age-related ND cognitive decline, Tinnitus | Flavonoids; terpenoids → vasodilation; antioxidant; cerebral perfusion | Strong |
Turmeric/Curcumin | Root | Neuroinflammation, Alpha-synuclein (Parkinson's), Mood, Executive function, Gut-brain axis | Curcumin → NF-κB inhibition; Nrf2; anti-inflammatory; BBB crossing | Strong (preclinical); Moderate (human) |
Mucuna Pruriens | Legume/Bean | Dopamine deficiency symptoms in ND (motivation, reward, RSD), Motor (PD) | Natural L-DOPA → dopamine precursor; mood; motor | Strong (PD); Moderate (mood/dopamine) |
Magnesium Glycinate | Mineral | Sleep, Anxiety, Nervous system downregulation, Sensory hypersensitivity, Muscle tension from motor difficulties | NMDA receptor modulation; GABA support; muscle relaxant; melatonin co-factor | Strong |
L-Theanine | Amino Acid (Tea) | Anxiety, Focus quality, Sleep onset, Sensory overwhelm, Overstimulation | GABA; alpha wave induction; reduces glutamate excitotoxicity | Strong (anxiety/focus); Moderate (sleep) |
Saffron | Spice | Depression overlap with ND, Emotional regulation, RSD, OCD symptoms | Safranal; crocin → serotonin reuptake inhibition; neuroprotective | Moderate-Strong (depression/mood RCTs) |
Domain 1: Emotional Regulation
Emotional dysregulation isn't a character flaw wearing a neurological costume. It's structural. The prefrontal cortex modulates the amygdala through dopamine and norepinephrine — and in most ND profiles, that circuit runs compromised. (Barkley, 2015; Shaw et al., 2014)
The feeling isn't disproportionate. The architecture is different.
Three pathways in: HPA axis regulation, neurotransmitter support, and direct neural circuit repair via NGF and BDNF. Sleep sits underneath all three — one bad night measurably reduces prefrontal-amygdala inhibitory connectivity. The biology is that fast. That fragile. That real.
Supplement | Specific Emotional Regulation Support | Dose / Timing | Key Evidence |
Ashwagandha | Reduces cortisol — the physiological substrate of emotional overwhelm; GABA-A modulation creates structural calm without sedation; directly reduces amygdala hyperreactivity in animal studies | 300–600 mg KSM-66 with food; evening for cortisol peak | Chandrasekhar et al., 2012 |
Rhodiola Rosea | MAO-A and MAO-B inhibition modulates both norepinephrine (emotional intensity) and dopamine (emotional motivation/reward); reduces emotional fatigue under stress | 200–400 mg morning; cycle use | Olsson et al., 2009 |
Bacopa Monnieri | Anxiolytic via GABA pathway; reduces cortisol; improves the prefrontal cortex's capacity to modulate limbic responses — the top-down regulation that ND emotional dysregulation lacks | 300 mg with fat; 8–12 weeks for effect | Roodenrys et al., 2002 |
Lion's Mane | NGF and BDNF stimulation supports hippocampal and prefrontal integrity — the structures central to emotional memory regulation; reduces depression and anxiety scores | 1,000–2,000 mg daily; 4–8 weeks | Nagano et al., 2010 |
Reishi | Reduces inflammatory cytokines that drive emotional sensitivity; lowers cortisol; improves sleep — which is the most important single factor in emotional regulation capacity | 1,000–2,000 mg evening | — |
Saffron | Serotonin reuptake inhibition comparable to low-dose SSRIs in RCTs; specifically supports emotional baseline and reduces emotional lability | 30 mg/day (standardized extract); Safranal + Crocin | Hausenblas et al., 2013 |
Magnesium Glycinate | NMDA receptor modulation reduces excitatory overload; GABA co-factor; depleted by chronic stress — which is near-universal in ND people navigating neurotypical environments | 200–400 mg before bed | Boyle et al., 2017 |
💡 Practical Sequence Start with Ashwagandha (addresses the cortisol substrate) and Magnesium Glycinate (addresses the excitatory overload) before adding cognitively active supplements like Bacopa or Lion's Mane. Give the nervous system a base of safety before adding stimulation. |
Domain 2: Rejection Sensitive Dysphoria (RSD)
The pain is real. Not metaphorical, not dramatic, not a personality trait that needs managing. A neurological event — noradrenergic and dopaminergic dysregulation firing the moment rejection lands. Or seems to land. The body doesn't wait for confirmation. (Dodson, 2016; Barkley, 2015)
Supplements don't eliminate RSD. What they can do: raise the threshold. Reduce the amplitude. Shift the reward-pain balance slightly back toward center — so the signal still arrives, but doesn't detonate.
Two levers. Calming baseline noradrenergic hyperreactivity, so the trigger requires more to pull. Supporting dopamine availability, so social pain doesn't land into a system already running on empty.
L-Theanine is the exception to the slow-build rule. It works fast. Useful in the moment — not as a cure, but as a physiological handbrake on the escalation.
Supplement | Anxiety / RSD Support | Dose / Timing | Key Evidence |
Ashwagandha | Multiple RCTs confirm anxiolytic effects via GABA-A modulation and cortisol reduction; reduces perceived stress, panic frequency, and generalized anxiety; one of the best-evidenced natural anxiolytics available | 300–600 mg KSM-66; with food; especially evening | Chandrasekhar et al., 2012; Lopresti et al., 2019 |
Bacopa Monnieri | Reduces cortisol and DHEA-S in anxious adults; supports prefrontal regulation of limbic anxiety responses; particularly helpful for anticipatory and social anxiety | 300 mg standardized; with fat; 8–12 weeks | Calabrese et al., 2008 |
L-Theanine | Directly reduces alpha-amylase (a stress biomarker); reduces subjective anxiety and physiological arousal without sedation; fast-acting — works within 30–60 minutes; ideal for acute RSD moments | 100–400 mg as needed or daily | Kimura et al., 2007 |
Rhodiola | Specifically reduces performance anxiety and social anxiety under stress conditions; MAO inhibition modulates norepinephrine surges — directly relevant to RSD's noradrenergic component | 200–400 mg morning | Shevtsov et al., 2003 |
Valerian Root | GABA-A agonism; reduces anxiety without cognitive dulling; particularly effective for the hyperarousal anxiety pattern common in ADHD and Autism | 300–600 mg; evening or pre-stressor | Bent et al., 2006 |
Saffron | Serotonin reuptake inhibition shown to reduce anxiety and depression scores in RCTs comparable to fluoxetine at low doses; the serotonergic component of RSD is under-discussed and saffron addresses it directly | 30 mg/day standardized extract | Hausenblas et al., 2013 |
Mucuna Pruriens | Natural L-DOPA raises dopamine — the neurotransmitter most directly implicated in RSD. Low dopamine drives social pain hypersensitivity. Not a first-line supplement but relevant in dopamine-depletion states | Variable; start low; consult practitioner | Katzenschlager et al., 2004 |
Magnesium Glycinate | Anxiety in ND is often partly driven by magnesium deficiency — which increases NMDA receptor excitotoxicity and reduces GABA activity. Correcting depletion reduces baseline anxiety significantly | 300–400 mg; evening | Boyle et al., 2017 |
Holy Basil | Reduces cortisol and adrenaline post-stressor; specifically useful for the residual anxiety that lingers after social situations and masking-heavy days | 500 mg extract; daily | Cohen, 2014 |
🔬 The Dopamine-RSD Connection RSD is, in part, a low-dopamine phenomenon. The dopamine system is the brain's reward and social salience system — when it is dysregulated, social pain is amplified and social reward is muted. Mucuna Pruriens (natural L-DOPA), Panax Ginseng, and Rhodiola all support dopaminergic function and are worth considering in RSD-dominant profiles. This is not a replacement for behavioral and relational strategies — it is a biological floor to work from. |
Domain 3: Sensory Processing
The thalamus is supposed to filter. In hypersensitive profiles, it doesn't — or doesn't enough. Sensory signals arrive at full volume, unedited, and the stress system responds accordingly. (Marco et al., 2011; Dunn, 2001)
Then the amplifiers kick in. Neuroinflammation turns up the gain. Cortisol turns up the gain. One bad night's sleep turns up the gain. By the time the fluorescent light or the seam in the sock registers, the nervous system is already three inputs past its limit.
Nothing here fixes sensory processing. That's not the goal — sensory differences aren't pathology. The goal is the threshold. Lower the nervous system's baseline activation, and the same input lands differently. Not silenced. Just survivable.
Supplement | Nervous System Regulation Support | Dose / Timing | Key Evidence |
Ashwagandha | The most evidence-backed HPA axis regulator available. Reduces cortisol, reduces amygdala hyperreactivity, improves vagal tone markers, reduces sympathetic overdrive — directly addresses chronic hyperarousal | 300–600 mg KSM-66; evening dosing for cortisol peak | Chandrasekhar et al., 2012; Pratte et al., 2014 |
Magnesium Glycinate | Magnesium is the primary physiological brake on NMDA-receptor excitatory overload — the main driver of sensory and nervous system hyperreactivity. Chronically depleted by stress. Glycinate form is best absorbed and least likely to cause GI upset | 300–400 mg before bed; or split morning/evening | Boyle et al., 2017; Abbasi et al., 2012 |
Reishi | Triterpenoids modulate the TH1/TH2 immune balance — relevant because neuroinflammation drives nervous system hypersensitivity; also reduces cortisol and supports sleep architecture | 1,000–3,000 mg; evening | — |
Holy Basil (Tulsi) | Eugenol and ursolic acid reduce cortisol, inhibit COX-2 inflammatory pathways, and support adrenal recovery; strong traditional use for nervous system support is backed by emerging pharmacology | 500–1,000 mg extract; morning or split | Cohen, 2014 |
L-Theanine | Directly induces alpha-wave brain activity — the calm-alert state that represents optimal nervous system regulation; GABA modulation without sedation; within 30–60 minutes of intake | 100–200 mg; as needed or daily | Juneja et al., 1999 |
Valerian Root | Valerenic acid binds GABA-A receptors — the same target as benzodiazepines but without dependency risk; most effective for the overactivated evening state that prevents downregulation for sleep | 300–600 mg 1 hour before bed | Bent et al., 2006 |
Schisandra | Adaptogen that specifically supports liver clearance of stress hormones (cortisol, adrenaline metabolites) while also having direct CNS adaptogenic properties; used for emotional reactivity and recovery | 500 mg twice daily with food | Panossian & Wikman, 2008 |
Rhodiola | Supports recovery of the HPA axis after sustained stress; reduces cortisol response amplitude without eliminating appropriate cortisol responses; reduces burnout and exhaustion | 200–400 mg morning; cycle use | Olsson et al., 2009 |
💡 Sensory Threshold vs. Sensory Difference The goal is not to suppress sensory awareness — it is to reduce the nervous system's state of alarm so that sensory input is processed rather than triggering an immediate threat cascade. Magnesium and Ashwagandha are the most direct routes to this. L-Theanine is useful before known high-sensory situations. |
Domain 4: Executive Function
Not lazy. Not unmotivated. Neurochemically under-resourced. The prefrontal cortex runs on dopamine and norepinephrine — and when supply is inconsistent, the executive system doesn't reliably come online. Wanting to perform isn't the variable. Chemistry is. (Barkley, 2011; Brown, 2013)
The supplement approach has three layers. Hardware: Lion's Mane and Bacopa rebuilding the neural circuits themselves. Fuel: Ginseng and Rhodiola supporting the neurotransmitter supply those circuits run on. Energy: Cordyceps at the mitochondrial level, where ATP production determines whether the prefrontal cortex has anything to work with at all.
This is slow work. Bacopa takes 12 weeks. Lion's Mane takes 4–8. The urgency-interest circuit that ADHD runs on will not be rewired in a week.
Start anyway.
Supplement | Executive Function Support | Dose / Timing | Key Evidence |
Lion's Mane | NGF stimulation promotes neuronal growth and myelination in prefrontal circuits — the exact circuits that underpin executive function; BDNF supports working memory substrate | 1,000–3,000 mg daily; builds over 4–8 weeks | Mori et al., 2009; Lai et al., 2013 |
Bacopa Monnieri | Acetylcholinesterase inhibition directly supports working memory; increases synaptic density in frontal and hippocampal regions; reduces cognitive load from anxiety | 300 mg standardized; with fat; 12 weeks for peak | Roodenrys et al., 2002; Morgan & Stevens, 2010 |
Rhodiola Rosea | Reduces mental fatigue — the practical limiting factor of executive function; supports task initiation and sustained cognitive effort under stress; fast-acting | 200–400 mg morning on empty stomach | Shevtsov et al., 2003 |
Panax Ginseng | Increases dopamine and norepinephrine availability — the exact neurotransmitters that executive function depends on; improves working memory, processing speed, and reaction time | 200–400 mg standardized (ginsenosides) | Reay et al., 2005 |
Ginkgo Biloba | Increases cerebral blood flow to frontal lobes; improves memory retrieval and processing speed; particularly effective for working memory in adults with age-related EF decline | 120–240 mg standardized; morning | Oken et al., 1998 |
Cordyceps | ATP production increase directly supports the energy demands of prefrontal activity; reduces cognitive fatigue; particularly useful for initiation deficits driven by energy depletion | 1,000–2,000 mg morning | Chen et al., 2010 |
L-Theanine (+ caffeine) | L-Theanine alone increases alpha-wave activity and focus quality; combined with caffeine (50/100 mg ratio) shows improved attention, speed of response, and reduced task-switching errors | 100–200 mg L-Theanine; with or without low-dose caffeine | Haskell et al., 2008 |
⚠️ Important Rhodiola has MAO-inhibiting properties and should be used with caution alongside stimulant medication. Panax Ginseng is stimulating and may amplify medication effects. Consult your prescriber. Bacopa and Lion's Mane have no known stimulant interactions and are generally safe alongside ADHD medication. |
Domain 5: Nervous System Regulation
Too much or not enough. The ND autonomic nervous system rarely finds the middle — it runs hot, or it collapses. Sympathetic overdrive or dorsal vagal shutdown. Both feel like survival. Neither is sustainable. (Porges, 2011; Panossian & Wikman, 2010)
Adaptogens are pharmacologically defined by one thing: the ability to normalize HPA axis function in both directions. Not suppress. Not stimulate. Calibrate.
This is the foundation. Emotional regulation sits on top of it. Sensory processing sits on top of it. Executive function sits on top of it. Everything else in this guide depends on this working first.
Not an add-on. The beginning.
Supplement | Nervous System Regulation Support | Dose / Timing | Key Evidence |
Ashwagandha | The most evidence-backed HPA axis regulator available. Reduces cortisol, reduces amygdala hyperreactivity, improves vagal tone markers, reduces sympathetic overdrive — directly addresses chronic hyperarousal | 300–600 mg KSM-66; evening dosing for cortisol peak | Chandrasekhar et al., 2012; Pratte et al., 2014 |
Magnesium Glycinate | Magnesium is the primary physiological brake on NMDA-receptor excitatory overload — the main driver of sensory and nervous system hyperreactivity. Chronically depleted by stress. Glycinate form is best absorbed and least likely to cause GI upset | 300–400 mg before bed; or split morning/evening | Boyle et al., 2017; Abbasi et al., 2012 |
Reishi | Triterpenoids modulate the TH1/TH2 immune balance — relevant because neuroinflammation drives nervous system hypersensitivity; also reduces cortisol and supports sleep architecture | 1,000–3,000 mg; evening | — |
Holy Basil (Tulsi) | Eugenol and ursolic acid reduce cortisol, inhibit COX-2 inflammatory pathways, and support adrenal recovery; strong traditional use for nervous system support is backed by emerging pharmacology | 500–1,000 mg extract; morning or split | Cohen, 2014 |
L-Theanine | Directly induces alpha-wave brain activity — the calm-alert state that represents optimal nervous system regulation; GABA modulation without sedation; within 30–60 minutes of intake | 100–200 mg; as needed or daily | Juneja et al., 1999 |
Valerian Root | Valerenic acid binds GABA-A receptors — the same target as benzodiazepines but without dependency risk; most effective for the overactivated evening state that prevents downregulation for sleep | 300–600 mg 1 hour before bed | Bent et al., 2006 |
Schisandra | Adaptogen that specifically supports liver clearance of stress hormones (cortisol, adrenaline metabolites) while also having direct CNS adaptogenic properties; used for emotional reactivity and recovery | 500 mg twice daily with food | Panossian & Wikman, 2008 |
Rhodiola | Supports recovery of the HPA axis after sustained stress; reduces cortisol response amplitude without eliminating appropriate cortisol responses; reduces burnout and exhaustion | 200–400 mg morning; cycle use | Olsson et al., 2009 |
Domain 6: Anxiety & Threat Detection
Most ND anxiety isn't a disorder sitting alongside the neurodivergence. It's what chronic mismatch produces. A nervous system that has been on alert long enough starts treating alert as baseline. (Ung et al., 2013; White et al., 2009)
Reduce the mismatch — the sensory overload, the executive failures, the social unpredictability, the daily cost of masking — and the anxiety often follows it down. That's not a supplement insight. That's the whole argument for neuroinclusive design.
Supplements work on the substrate. The cortisol. The amygdala hair-trigger. The threat-detection system that can't tell the difference between a deadline and a predator. Not treating the anxiety as the problem. Treating the biology that's feeding it.
Supplement | Anxiety / RSD Support | Dose / Timing | Key Evidence |
Ashwagandha | Multiple RCTs confirm anxiolytic effects via GABA-A modulation and cortisol reduction; reduces perceived stress, panic frequency, and generalized anxiety; one of the best-evidenced natural anxiolytics available | 300–600 mg KSM-66; with food; especially evening | Chandrasekhar et al., 2012; Lopresti et al., 2019 |
Bacopa Monnieri | Reduces cortisol and DHEA-S in anxious adults; supports prefrontal regulation of limbic anxiety responses; particularly helpful for anticipatory and social anxiety | 300 mg standardized; with fat; 8–12 weeks | Calabrese et al., 2008 |
L-Theanine | Directly reduces alpha-amylase (a stress biomarker); reduces subjective anxiety and physiological arousal without sedation; fast-acting — works within 30–60 minutes; ideal for acute RSD moments | 100–400 mg as needed or daily | Kimura et al., 2007 |
Rhodiola | Specifically reduces performance anxiety and social anxiety under stress conditions; MAO inhibition modulates norepinephrine surges — directly relevant to RSD's noradrenergic component | 200–400 mg morning | Shevtsov et al., 2003 |
Valerian Root | GABA-A agonism; reduces anxiety without cognitive dulling; particularly effective for the hyperarousal anxiety pattern common in ADHD and Autism | 300–600 mg; evening or pre-stressor | Bent et al., 2006 |
Saffron | Serotonin reuptake inhibition shown to reduce anxiety and depression scores in RCTs comparable to fluoxetine at low doses; the serotonergic component of RSD is under-discussed and saffron addresses it directly | 30 mg/day standardized extract | Hausenblas et al., 2013 |
Mucuna Pruriens | Natural L-DOPA raises dopamine — the neurotransmitter most directly implicated in RSD. Low dopamine drives social pain hypersensitivity. Not a first-line supplement but relevant in dopamine-depletion states | Variable; start low; consult practitioner | Katzenschlager et al., 2004 |
Magnesium Glycinate | Anxiety in ND is often partly driven by magnesium deficiency — which increases NMDA receptor excitotoxicity and reduces GABA activity. Correcting depletion reduces baseline anxiety significantly | 300–400 mg; evening | Boyle et al., 2017 |
Holy Basil | Reduces cortisol and adrenaline post-stressor; specifically useful for the residual anxiety that lingers after social situations and masking-heavy days | 500 mg extract; daily | Cohen, 2014 |
Domain 7: Memory & Cognitive Processing
The mental whiteboard that erases mid-sentence. The word that was there a second ago. The processing that works perfectly — just not at the speed the room is moving. None of that is intelligence. It's
architecture meeting a system that wasn't designed for it. (Gathercole & Alloway, 2008; Eide & Eide, 2011)
Four layers working together: neurogenesis and neuroprotection via Lion's Mane, memory consolidation via Bacopa, cerebral circulation via Ginkgo and Ginseng, cognitive fatigue reduction via Rhodiola.
They're synergistic. They're also slow.
You are rebuilding infrastructure. Not flipping a switch.
Supplement | Cognitive / Memory Support | Dose / Timing | Key Evidence |
Lion's Mane | Directly stimulates NGF and BDNF — growth factors that increase synaptic density, support myelination, and protect existing neurons; the foundational cognitive supplement for ND profiles | 1,000–3,000 mg; dual-extract fruiting body; daily | Mori et al., 2009; Lai et al., 2013 |
Bacopa | Strongest evidence for memory consolidation of any natural supplement; improves recall, spatial memory, and processing speed; acetylcholinesterase inhibition directly addresses working memory fragility | 300 mg standardized (45% bacosides); with fat; 12 weeks | Roodenrys et al., 2002 |
Ginkgo Biloba | Increases cerebral blood flow; improves cognitive processing speed and working memory; particularly useful for the processing speed slowdown that affects Dyslexia and ADHD profiles | 120–240 mg standardized; morning | Oken et al., 1998 |
Panax Ginseng | Improves working memory, attention, and processing speed via dopamine/NE support and cerebral microcirculation; also improves glucose metabolism in brain cells | 200–400 mg standardized | Reay et al., 2005 |
Rhodiola | Primarily reduces cognitive fatigue — the main reason variable ND performance crashes; restores cognitive function under stress; particularly helpful for Dyslexia and ADHD-driven processing bottlenecks | 200–400 mg morning | Shevtsov et al., 2003 |
Curcumin (BCM-95) | Crosses the blood-brain barrier; reduces neuroinflammation — a driver of cognitive fog in many ND profiles; supports BDNF; anti-amyloid; particularly relevant in aging ND adults | 500 mg BCM-95 with fat; daily | Small et al., 2018 |
Domain 8: Sleep Architecture & Rhythms
Two thirds to four fifths of ND adults don't sleep well. That's not a lifestyle issue. That's a number that points directly at biology. (Cortese et al., 2006; Van der Heijden et al., 2005)
Four mechanisms, usually running simultaneously. Evening cortisol that won't clear — so the body stays activated when it should be winding down. Melatonin that releases late — shifting the entire sleep window into hours the world won't accommodate. A nervous system too hyperaroused to downregulate. And a sensory environment that never quite gets quiet enough.
All four are targetable. That's the rare good news in this domain.
Supplement | Sleep Support in ND Context | Dose / Timing | Key Evidence |
Magnesium Glycinate | The most important sleep supplement for ND profiles. Corrects near-universal deficiency; reduces NMDA excitotoxicity that prevents sleep onset; supports melatonin synthesis; reduces muscle tension from motor difficulties; reduces nighttime anxiety | 300–400 mg 30–60 min before bed | Abbasi et al., 2012 |
Ashwagandha | Directly reduces evening cortisol — the most common reason ND brains cannot shut down at night; also reduces sleep latency and improves sleep quality scores in RCTs | 300–600 mg KSM-66 with evening meal | Langade et al., 2019 |
Reishi | Triterpenoids support sleep depth and duration; reduces immune-mediated sleep disruption; particularly useful for the frequent ND pattern of waking at 3am due to cortisol rebound | 1,000–3,000 mg 1–2 hours before bed | Cui et al., 2012 |
Valerian Root | GABA-A agonism reduces sleep onset latency; especially effective in the hyperaroused ND pattern; combines well with Magnesium for a non-pharmaceutical sleep stack | 300–600 mg 30–60 min before bed | Bent et al., 2006 |
L-Theanine | Induces alpha-wave activity that bridges the hyperaroused waking state and sleep onset; reduces racing thoughts; child-safe and gentle — important for ND children with sleep difficulties | 100–200 mg before bed | Rao et al., 2015 |
Lion's Mane | NGF and BDNF support healthy sleep architecture over time — not an acute sleep aid, but improves sleep quality as a side-effect of overall neural health restoration | 1,000–2,000 mg; timing flexible | Nagano et al., 2010 |
Holy Basil | Reduces cortisol and adrenaline load accumulated during the day; supports transition to parasympathetic dominance in the evening; useful for the 'wired but tired' ND pattern | 500 mg; late afternoon or early evening | Cohen, 2014 |
📋 The ND Sleep Stack The most effective natural sleep protocol for ND brains: Magnesium Glycinate 400 mg + Ashwagandha 300 mg + Reishi 1,500 mg taken together 45–60 minutes before bed. Add Valerian 300–600 mg if sleep onset is the primary issue. Add L-Theanine 200 mg if racing thoughts are the barrier. This combination addresses cortisol, GABA, nervous system downregulation, and sleep architecture simultaneously — without dependency risk. |
Domain 9: Motor Function, Coordination & Physical Fatigue
The energy cost is invisible to everyone except the person paying it. Walking. Writing. Holding a pen without gripping too hard. Sitting in a chair without actively managing where your body is in space. For neurotypical people these are automatic. For Dyspraxia, Autism, and hypermobile profiles, they are effortful — and effort accumulates. (Chen et al., 2010; Lai et al., 2013)
By midday the fatigue is real and the cause is invisible. That gap — between what it looked like you did and what it actually cost — is where a lot of ND people lose the narrative about themselves.
Three levers. ATP production — Cordyceps, working at the mitochondrial level where motor effort draws its fuel. Nerve conduction efficiency — Lion's Mane, supporting the growth and integrity of the pathways that carry motor signals. Inflammation and muscle tension — Curcumin and Magnesium, addressing what accumulates when the system has been working harder than anyone can see.
Supplement | Motor / Sensory Support | Dose / Timing | Key Evidence |
Cordyceps | Increases ATP production in muscle and neural tissue; reduces physical fatigue from motor exertion; supports endurance in people with Dyspraxia for whom basic physical coordination requires far more energy than it does for others | 1,500–2,000 mg morning | Chen et al., 2010 |
Lion's Mane | Nerve growth factor stimulation supports peripheral nerve function and myelination — directly relevant to the motor coordination and fine motor difficulties in Dyspraxia | 1,000–2,000 mg daily | Lai et al., 2013 |
Magnesium Glycinate | Muscle tension, cramping, and fatigue from motor effort are all addressed; also reduces sensory hypersensitivity via NMDA modulation; essential for Dyspraxia and hypermobile ND profiles (hEDS overlap) | 300–400 mg; can split morning/evening | Boyle et al., 2017 |
Curcumin | Anti-inflammatory for muscle and joint pain from motor over-exertion; also reduces neuroinflammation that contributes to sensory hypersensitivity and the physical pain of RSD | 500 mg BCM-95 with piperine; with food | Hewlings & Kalman, 2017 |
CoQ10 | Mitochondrial support for the disproportionate energy cost of motor tasks in DCD/Dyspraxia and hypermobile ND profiles; particularly relevant when fatigue is a major feature | 100–300 mg with fat; morning | Littarru & Tiano, 2010 |
Ashwagandha | Reduces the physical stress response that amplifies sensory sensitivity; also reduces the cortisol load from a sensory-heavy day; supports recovery of the nervous system after sensory overwhelm | 300–600 mg; timing depends on primary use case | Chandrasekhar et al., 2012 |
Domain 10: Burnout & Depression
Burnout isn't exhaustion. It's a different category entirely.
It's what happens when a nervous system has been running beyond its actual capacity for long enough that the pretending stops. For autistic people that looks like losing previously held skills — the capacity to speak, to tolerate light, to leave the house. For ADHD it looks like executive and emotional resources depleting until the system simply won't start. For anyone chronically overloaded in an environment that wasn't built for them, it looks like collapse that rest alone doesn't fix. (Raymaker et al., 2020)
Depression lives in the same biological neighborhood. HPA axis dysregulation. Neuroinflammation. Mitochondrial depletion. Dopamine and serotonin systems running on empty. The line between burnout and depression is often not a line at all — it's a gradient, and most people arrive at one through the other. (Barkley, 2015; Hausenblas et al., 2013)
The fingerprints are the same. The body didn't fail. It responded rationally to an unsustainable demand.
Supplements can support recovery. They cannot accelerate it. The sequence matters more than the selection.
First: stabilize the HPA axis. Ashwagandha. Nothing else yet. The system needs a floor before it can build.
Then: the gut-brain axis. Turkey Tail. Then sleep — Magnesium, Reishi. Then neuroprotection and serotonin support — Lion's Mane, Saffron. Dopamine precursor support via Mucuna only once the system is stable enough to receive it.
Only then does anything stimulating belong in the picture.
Rhodiola in acute burnout is the wrong answer to the right question. The question is real. The timing isn't.
Supplement | Burnout & Depression Support | Dose / Timing | Notes |
Ashwagandha | The floor. HPA axis rehabilitation after sustained overload — cortisol down, thyroid function restored, adrenal capacity rebuilt. In depression: directly reduces cortisol-driven mood dysregulation. Start here. Stay here until stable. | 600 mg KSM-66 twice daily; with food | Chandrasekhar et al., 2012 |
Rhodiola | Not for acute burnout. Not for active depression. For the middle phase — when the floor is solid and fatigue is what remains. Studied directly in burnout populations. Introduce only after Ashwagandha has done its work. | 200–400 mg morning; after Ashwagandha baseline | Olsson et al., 2009 |
Reishi | Burnout and depression share an immune-neurological signature: cytokine cascades that drive both exhaustion and mood collapse. Reishi addresses the inflammatory driver while rebuilding sleep. Quiet work. Long game. | 2,000–3,000 mg; evening; long-term | — |
Eleuthero | The bridge supplement. Mild enough for the phase between acute crash and full recovery — when Ashwagandha has stabilized but Rhodiola is still too much. | 1,000–2,000 mg daily; cycle | — |
Schisandra | Stress hormones are metabolized in the liver. Burnout and depression both flood it. Schisandra clears the backlog while supporting the emotional reactivity that spikes when the system is depleted. | 500 mg twice daily with meals | Panossian & Wikman, 2008 |
Lion's Mane | The prefrontal cortex takes the hardest hit in both burnout and depression. NGF and BDNF support its recovery. Neural repair after sustained overload. Slow. Necessary. | 2,000–3,000 mg daily; build over weeks | Mori et al., 2009 |
Turkey Tail | The gut microbiome is one of the first casualties of chronic stress and depression. The gut-brain axis is not peripheral to mood recovery — it is central to it. Turkey Tail rebuilds the foundation. | 1,500–2,000 mg daily; long-term | Torkelson et al., 2012 |
Saffron | The depression-specific entry. Serotonin reuptake inhibition comparable to low-dose SSRIs in RCTs. The serotonergic floor that burnout and depression both erode. | 30 mg standardized extract daily | Hausenblas et al., 2013 |
⚠️ Important Burnout is not tiredness. Depression is not sadness. Neither responds to pushing through. Stimulating supplements in an acute burnout or depressive state — Rhodiola, Cordyceps, Panax Ginseng, even high-dose Lion's Mane — ask a system that has stopped to run faster. It won't. It will get worse. The acute protocol is the same for both: Ashwagandha. Magnesium. Reishi. Turkey Tail. Saffron. Sleep. That's the floor. Nothing more until it's stable. Supplements are not a substitute for medical or psychiatric care. If you are in burnout, in a depressive episode, or not sure which — please reach out to a professional. The list below is a starting point. If you need support:
You don't have to figure out the protocol before you ask for help. Ask first. |
Practical Protocols: By ND Profile
Every nervous system is different. These stacks are starting points — not prescriptions. Medication interactions, budget, and how your particular biology responds will all shape what actually works.
One or two supplements. Four to eight weeks. Track what shifts.
If sleep is the primary issue — start there. Everything else in this guide works better on a nervous system that has actually rested. The most direct sleep stack: Magnesium Glycinate, Ashwagandha, Reishi. That combination addresses cortisol, GABA, and sleep architecture simultaneously — without dependency risk.
The ND Sleep Stack
Magnesium Glycinate 400 mg + Ashwagandha 300 mg + Reishi 1,500 mg — together, 45–60 minutes before bed.
Add Valerian 400 mg if sleep onset is the primary issue. Add L-Theanine 200 mg if racing thoughts are the barrier. Add Lion's Mane 1,000 mg in the morning (not at night) for sleep architecture repair over time.
This stack addresses cortisol, GABA, nervous system downregulation, and sleep architecture simultaneously. No dependency risk. Give it four weeks before evaluating.
Supplements are one layer. The nervous system also responds to what you do with your body and attention. Breathwork, somatic practices, cold exposure, vagal toning exercises, and meditation all work on the same HPA axis and autonomic pathways that the supplements in this guide target. They are not alternatives to each other — they are the same conversation, in different languages.
If you are new to nervous system regulation practices, start with the physiological sigh — a double inhale through the nose followed by a long exhale through the mouth. It is the fastest evidence-backed way to manually downregulate the sympathetic nervous system. Thirty seconds. Anywhere. Free.
ND Profile / Primary Friction | Morning Stack | Evening Stack | As Needed |
ADHD — Executive Function + Emotional Regulation | Lion's Mane 1,500 mg + Rhodiola 200 mg + Panax Ginseng 200 mg + Bacopa 300 mg (with breakfast) | Ashwagandha 300 mg + Reishi 1,500 mg + Magnesium Glycinate 300 mg | L-Theanine 100–200 mg for acute focus or RSD moments |
Autism — Sensory + Nervous System + Social Fatigue | Ashwagandha 300 mg + Lion's Mane 1,500 mg + Cordyceps 1,000 mg | Reishi 2,000 mg + Magnesium Glycinate 400 mg + Valerian 300 mg (if sleep disrupted) | L-Theanine 200 mg before high-sensory situations |
RSD — Emotional Pain + Anxiety | Rhodiola 200 mg + L-Theanine 200 mg + Holy Basil 500 mg | Ashwagandha 600 mg + Magnesium 400 mg + Saffron 30 mg | L-Theanine 200 mg + Bacopa 300 mg (ongoing) |
ND Burnout Recovery | Ashwagandha 600 mg + Eleuthero 1,000 mg + Turkey Tail 1,500 mg | Reishi 2,000 mg + Schisandra 500 mg + Magnesium 400 mg | Lion's Mane 2,000 mg daily throughout |
Sleep — Delayed Phase + Onset Difficulties | Ashwagandha 300 mg (morning) + Cordyceps 1,000 mg (energy/rhythm) | Magnesium Glycinate 400 mg + Reishi 1,500 mg + Valerian 450 mg + L-Theanine 200 mg | Holy Basil 500 mg if wired but tired |
Dyslexia / Dyspraxia — Cognitive + Motor | Lion's Mane 2,000 mg + Bacopa 300 mg + Ginkgo 120 mg + CoQ10 150 mg | Magnesium Glycinate 400 mg + Ashwagandha 300 mg | Cordyceps 1,000 mg before physical demands |
Memory + Processing Speed (all ND) | Lion's Mane 2,000 mg + Bacopa 300 mg + Rhodiola 200 mg + Ginkgo 120 mg | Reishi 1,500 mg + Magnesium 300 mg | L-Theanine for focus quality; Panax Ginseng if cognitive fatigue high |
Burnout (acute phase) | Ashwagandha 600 mg + Eleuthero 500 mg (no Rhodiola yet) | Reishi 3,000 mg + Magnesium 400 mg + Valerian 600 mg | Turkey Tail 1,500 mg daily; Lion's Mane 2,000 mg; no stimulating supplements |
💡 On Sequencing The most important sequencing principle: nervous system regulation before cognitive enhancement. An unregulated nervous system cannot absorb the benefits of cognitive supplements — and stimulating an already overloaded system worsens the core problem. Ashwagandha + Magnesium first. Everything else second. |
Choosing Quality Supplements
The supplement industry is largely unregulated. The label is not the product.
Mushrooms. Fruiting body only. Dual-extract — hot water for beta-glucans, alcohol for triterpenoids. Verified beta-glucan content on the label: 25%+ for Lion's Mane. Most cheap products are mycelium grown on grain — high starch, minimal actives. Third-party COA for heavy metals is non-negotiable. Mushrooms bioaccumulate whatever they grow in.
Ashwagandha. KSM-66 or Sensoril. Those are the two forms with actual RCT evidence behind them. Generic root powder has inconsistent withanolide content — the active compound that does the work.
Bacopa. Standardized to 45% bacosides. Taken with fat — non-negotiable for absorption. Cheap standardizations are inconsistent. Eight to twelve weeks before you evaluate it.
Rhodiola. 3% rosavins, 1% salidroside. Many products substitute Rhodiola crenulata — a different species, different pharmacology, different effect. Check the Latin name on the label.
Magnesium. Glycinate or Bisglycinate only. Oxide — the form in most cheap supplements — has 4% bioavailability. It doesn't reach the nervous system. It reaches the toilet.
Curcumin. Standard curcumin is nearly inert by the time it reaches the bloodstream. BCM-95, Longvida, phytosome, or piperine-enhanced formulations only. The bioavailability difference is not marginal — it is the difference between therapeutic and decorative.
L-Theanine. Suntheanine is the gold standard. Most standard L-Theanine is adequate — 98%+ purity is what you're looking for.
References
All citations follow APA 7th edition format.
Abbasi, B., Kimiagar, M., Sadeghniiat, K., Shirazi, M. M., Hedayati, M., & Rashidkhani, B. (2012). The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences, 17(12), 1161–1169.
Barkley, R. A. (2011). Barkley deficits in executive functioning scale (BDEFS). Guilford Press.
Barkley, R. A. (2015). Emotional dysregulation is a core component of ADHD. In R. A. Barkley (Ed.), Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (4th ed., pp. 81–115). Guilford Press.
Bent, S., Padula, A., Moore, D., Patterson, M., & Mehling, W. (2006). Valerian for sleep: A systematic review and meta-analysis. American Journal of Medicine, 119(12), 1005–1012. https://doi.org/10.1016/j.amjmed.2006.02.026
Boyle, N. B., Lawton, C., & Dye, L. (2017). The effects of magnesium supplementation on subjective anxiety and stress — A systematic review. Nutrients, 9(5), 429. https://doi.org/10.3390/nu9050429
Brown, T. E. (2013). A new understanding of ADHD in children and adults: Executive function impairments. Routledge.
Calabrese, C., Gregory, W. L., Leo, M., Kraemer, D., Bone, K., & Oken, B. (2008). Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly. Journal of Alternative and Complementary Medicine, 14(6), 707–713. https://doi.org/10.1089/acm.2008.0018
Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262. https://doi.org/10.4103/0253-7176.106022
Chen, S., Li, Z., Krochmal, R., Abrazado, M., Kim, W., & Cooper, C. B. (2010). Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects. Journal of Alternative and Complementary Medicine, 16(5), 585–590. https://doi.org/10.1089/acm.2009.0226
Cohen, M. M. (2014). Tulsi — Ocimum tenuiflorum: A herb for all reasons. Journal of Ayurveda and Integrative Medicine, 5(4), 251–259. https://doi.org/10.4103/0975-9476.146554
Cortese, S., Faraone, S. V., Konofal, E., & Lecendreux, M. (2006). Sleep in children with attention-deficit/hyperactivity disorder: Meta-analysis of subjective and objective studies. Journal of the American Academy of Child & Adolescent Psychiatry, 45(8), 894–904. https://doi.org/10.1097/01.chi.0000220840.22109.9e
Dodson, W. W. (2016). Emotional regulation and rejection sensitivity. ADDitude Magazine. https://www.additudemag.com
Dunn, W. (2001). The sensations of everyday life: Empirical, theoretical, and pragmatic considerations. American Journal of Occupational Therapy, 55(6), 608–620. https://doi.org/10.5014/ajot.55.6.608
Eide, B. L., & Eide, F. F. (2011). The dyslexic advantage: Unlocking the hidden potential of the dyslexic brain. Hudson Street Press.
Gathercole, S. E., & Alloway, T. P. (2008). Working memory and learning: A practical guide for teachers. SAGE Publications.
Haskell, C. F., Kennedy, D. O., Milne, A. L., Wesnes, K. A., & Scholey, A. B. (2008). The effects of L-theanine, caffeine and their combination on cognition and mood. Biological Psychology, 77(2), 113–122. https://doi.org/10.1016/j.biopsycho.2007.09.008
Hausenblas, H. A., Saha, D., Dubyak, P. J., & Anton, S. D. (2013). Saffron (Crocus sativus L.) and major depressive disorder: A meta-analysis of randomized clinical trials. Journal of Integrative Medicine, 11(6), 377–383. https://doi.org/10.3736/jintegrmed2013056
Hewlings, S. J., & Kalman, D. S. (2017). Curcumin: A review of its effects on human health. Foods, 6(10), 92. https://doi.org/10.3390/foods6100092
Hull, L., Petrides, K. V., Allison, C., Smith, P., Baron-Cohen, S., Lai, M.-C., & Mandy, W. (2017). 'Putting on my best normal': Social camouflaging in adults with autism spectrum conditions. Journal of Autism and Developmental Disorders, 47(8), 2519–2534. https://doi.org/10.1007/s10803-017-3166-5
Juneja, L. R., Chu, D. C., Okubo, T., Nagato, Y., & Yokogoshi, H. (1999). L-theanine — a unique amino acid of green tea and its relaxation effect in humans. Trends in Food Science & Technology, 10(6–7), 199–204. https://doi.org/10.1016/S0924-2244(99)00044-8
Katzenschlager, R., Evans, A., Manson, A., Patsalos, P. N., Ratnaraj, N., Watt, H., Timmermann, L., Van der Giessen, R., & Lees, A. J. (2004). Mucuna pruriens in Parkinson's disease: A double blind clinical and pharmacological study. Journal of Neurology, Neurosurgery & Psychiatry, 75(12), 1672–1677. https://doi.org/10.1136/jnnp.2003.028761
Kimura, K., Ozeki, M., Juneja, L. R., & Ohira, H. (2007). L-Theanine reduces psychological and physiological stress responses. Biological Psychology, 74(1), 39–45. https://doi.org/10.1016/j.biopsycho.2006.06.006
Lai, P.-L., Naidu, M., Sabaratnam, V., Wong, K.-H., David, R. P., Kuppusamy, U. R., Abdullah, N., & Malek, S. N. A. (2013). Neurotrophic properties of the Lion's Mane medicinal mushroom, Hericium erinaceus. Evidence-Based Complementary and Alternative Medicine, 2013, 492976. https://doi.org/10.1155/2013/492976
Langade, D., Kanchi, S., Salve, J., Debnath, K., & Ambegaokar, D. (2019). Efficacy and safety of ashwagandha root extract in insomnia and anxiety: A double-blind, randomized, placebo-controlled study. Cureus, 11(9), e5797. https://doi.org/10.7759/cureus.5797
Littarru, G. P., & Tiano, L. (2010). Clinical aspects of coenzyme Q10: An update. Nutrition, 26(3), 250–254. https://doi.org/10.1016/j.nut.2009.08.008
Lopresti, A. L., Smith, S. J., Malvi, H., & Kodgule, R. (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract. Medicine, 98(37), e17186. https://doi.org/10.1097/MD.0000000000017186
Marco, E. J., Hinkley, L. B. N., Hill, S. S., & Nagarajan, S. S. (2011). Sensory processing in autism: A review of neurophysiologic findings. Pediatric Research, 69(5 Pt 2), 48R–54R. https://doi.org/10.1203/PDR.0b013e3182130b54
Morgan, A., & Stevens, J. (2010). Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. Journal of Alternative and Complementary Medicine, 16(7), 753–759. https://doi.org/10.1089/acm.2009.0342
Mori, K., Inatomi, S., Ouchi, K., Azumi, Y., & Tuchida, T. (2009). Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment. Phytotherapy Research, 23(3), 367–372. https://doi.org/10.1002/ptr.2634
Nagano, M., Shimizu, K., Kondo, R., Hayashi, C., Sato, D., Kitagawa, K., & Ohnuki, K. (2010). Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research, 31(4), 231–237. https://doi.org/10.2220/biomedres.31.231
Oken, B. S., Storzbach, D. M., & Kaye, J. A. (1998). The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Archives of Neurology, 55(11), 1409–1415. https://doi.org/10.1001/archneur.55.11.1409
Olsson, E. M. G., von Schéele, B., & Panossian, A. G. (2009). A randomised, double-blind, placebo-controlled, parallel-group study of SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Medica, 75(2), 105–112. https://doi.org/10.1055/s-0028-1088346
Panossian, A., & Wikman, G. (2008). Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine. Journal of Ethnopharmacology, 118(2), 183–212. https://doi.org/10.1016/j.jep.2008.04.020
Panossian, A., & Wikman, G. (2010). Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals, 3(1), 188–224. https://doi.org/10.3390/ph3010188
Porges, S. W. (2011). The Polyvagal Theory: Neurophysiological foundations of emotions, attachment, communication, and self-regulation. W. W. Norton & Company.
Pratte, M. A., Nanavati, K. B., Young, V., & Morley, C. P. (2014). An alternative treatment for anxiety: A systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). Journal of Alternative and Complementary Medicine, 20(12), 901–908. https://doi.org/10.1089/acm.2014.0177
Rao, T. P., Ozeki, M., & Juneja, L. R. (2015). In search of a safe natural sleep aid. Journal of the American College of Nutrition, 34(5), 436–447. https://doi.org/10.1080/07315724.2014.926153
Raymaker, D. M., Teo, A. R., Steckler, N. A., Lentz, B., Scharer, M., Delos Santos, A., Kapp, S. K., Hunter, M., Joyce, A., & Nicolaidis, C. (2020). 'Having all of your internal resources exhausted beyond measure and being left with no clean-up crew': Defining autistic burnout. Autism in Adulthood, 2(2), 132–143. https://doi.org/10.1089/aut.2019.0079
Reay, J. L., Kennedy, D. O., & Scholey, A. B. (2005). Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mentally demanding tasks. Journal of Psychopharmacology, 19(4), 357–365. https://doi.org/10.1177/0269881105053286
Roodenrys, S., Booth, D., Bulzomi, S., Phipps, A., Micallef, C., & Smoker, J. (2002). Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology, 27(2), 279–281. https://doi.org/10.1016/S0893-133X(01)00419-5
Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2014). Emotion dysregulation in attention deficit hyperactivity disorder. American Journal of Psychiatry, 171(3), 276–293. https://doi.org/10.1176/appi.ajp.2013.13070966
Shevtsov, V. A., Zholus, B. I., Shervarly, V. I., Vol'skij, V. B., Korovin, Y. P., Khristich, M. P., Roslyakova, N. A., & Wikman, G. (2003). A randomized trial of two different doses of SHR-5 Rhodiola rosea extract versus placebo. Phytomedicine, 10(2–3), 95–105. https://doi.org/10.1078/094471103321659780
Small, G. W., Siddarth, P., Li, Z., Miller, K. J., Ercoli, L., Emerson, N. D., Martinez, J., Wong, K.-P., Liu, J., Merrill, D. A., Chen, S. T., Henning, S. M., Satyamurthy, N., Huang, S.-C., Heber, D., & Barrio, J. R. (2018). Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: A double-blind, placebo-controlled 18-month trial. American Journal of Geriatric Psychiatry, 26(3), 266–277. https://doi.org/10.1016/j.jagp.2017.10.010
Torkelson, C. J., Sweet, E., Martzen, M. R., Sasagawa, M., Wenner, C. A., Gay, J., Putiri, A., & Standish, L. J. (2012). Phase 1 clinical trial of Trametes versicolor in women with breast cancer. ISRN Oncology, 2012, 251632. https://doi.org/10.5402/2012/251632
Ung, D., Selles, R., Small, B. J., & Storch, E. A. (2013). A systematic review and meta-analysis of cognitive-behavioral therapy for anxiety in youth with high-functioning autism spectrum disorders. Child Psychiatry & Human Development, 46(4), 533–547. https://doi.org/10.1007/s10578-014-0494-y
Van der Heijden, K. B., Smits, M. G., Van Someren, E. J. W., & Gunning, W. B. (2005). Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: A circadian rhythm sleep disorder. Chronobiology International, 22(3), 559–570. https://doi.org/10.1081/CBI-200062410
White, S. W., Oswald, D., Ollendick, T., & Scahill, L. (2009). Anxiety in children and adolescents with autism spectrum disorders. Clinical Psychology Review, 29(3), 216–229. https://doi.org/10.1016/j.cpr.2009.01.003
© Alexandra Robuste Leadership Academy | For educational and professional use | Not a substitute for medical advice



Comments